Subscribe to Money Morning get daily headlines subscribe now! Money Morning Private Briefing today's private briefing Access Your Profit Alerts

Calithera Biosci Com (NASDAQ: CALA)

$15.90 USD $0.60 (3.92%)
Last Price $15.9
Net Change $0.6 (3.92%)
Bid $15.9
Ask Price $16
Open Price $15.25
Previous Close Price $15.3
High Price $16.2
Low Price $15.2
Number of Trades 1,997
Volume 379,536
Fifty Two Week High $17.4 (2017-05-23)
Fifty Two Week Low $2.2 (2016-10-27)
Average Daily Volume 794,688
Share Outstanding 35,290 Shares
Total Dividend Payout 0/yr
Dividend Yield 0%
1st Quarter Earnings $ ()
2nd Quarter Earnings $ ()
3nd Quarter Earnings $ ()
4th Quarter Earnings $ ()
PE Ratio $0
EPS Growth $43.08
Recent Earnings $
Annual EPS $-1.66
Last Quarter EPS $
Market Capitalization $0.56B
Insider Shareholders % 0.163%
Annual Revenue $0B
No. Shares Outstanding 35,290
Inst. Shareholder % 54.11%
Annual Net Income $-0.03B
TTM Net Profit Margin $-811.69
1-Year Return 206%
3-Year Return 62.59%
5-Year Return 62.59%
5-Year Revenue Growth 0%
5-Year Earnings Growth 0%
5-Year Dividend Growth 0%
Annual Dividend $0
Annual Dividend Yield 0%
Change in EPS YTD 43.080002%
Dividends per Share $
Stock Split Ratio
Beta 3.27
Calithera Biosciences, Inc. is a clinical-stage pharmaceutical company. It is focused on discovering and developing small molecule drugs directed against tumor metabolism and tumor immunology targets for the treatment of cancer. The Company's lead product candidate includes CB-839 which is in three Phase I clinical trials for the treatment of patients with solid tumors, leukemias, lymphomas, and multiple myeloma. Calithera Biosciences, Inc. is headquartered in South San Francisco, California.

CALA News & Stock Updates